Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kisvarda

8 clinical trials in Kisvarda, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kisvarda at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Kisvarda

Open in trial search

A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rinvecalinase alfa
  • Sponsor:Diamedica Therapeutics Inc.

Study on the Safety and Benefits of Recombinant Human Plasma Gelsolin for Patients with Moderate-to-Severe Acute Respiratory Distress Syndrome (ARDS)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Human Plasma Gelsolin, Recombinant
  • Sponsor:Bioaegis Therapeutics Inc.

Ischaemic stroke

Not yet recruiting

Study on Redasemtide for Adults with Acute Ischemic Stroke Not Eligible for Standard Treatments

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Redasemtide
  • Sponsor:Shionogi B.V.

Muscle spasticity

Not recruiting

Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Paresis

Not recruiting

Study on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Merz Pharmaceuticals GmbH

Study Comparing Gadoquatrane with Gadoteric Acid, Gadobutrol, and Gadoteridol for MRI in Adults with Brain or Spinal Cord Issues

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Gadobutrol
  • Sponsor:Bayer AG

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Other cities in Hungary

The busiest research cities in the country

All 71 cities in Hungary

Clinical research in Kisvarda

What the registry says about research in the country

01 Stroke Prevention & Treatment

Groundbreaking research focusing on ischemic stroke prevention and treatment, evaluating novel therapeutic approaches including oral inhibitors and specialized compounds.

  • Post-stroke Prevention
  • Transient Ischemic Attack Management
  • Blood Clot Prevention

Multiple studies are exploring innovative medications to reduce stroke recurrence risk in high-risk patients.

02 Neurological Imaging

Advanced research in contrast enhancement agents for magnetic resonance imaging, specifically targeting central nervous system pathology assessment.

  • Brain Imaging Advancement
  • Spinal Cord Diagnostics
  • MRI Enhancement Technology

Studies focus on developing safer and more effective contrast agents for neurological diagnosis.

03 Respiratory Medicine

Critical research into treatment options for Acute Respiratory Distress Syndrome, particularly cases resulting from pneumonia and other infections.

  • ARDS Treatment
  • Pneumonia Complications
  • Respiratory Care Innovation

Investigating novel protein-based therapies to improve patient outcomes in severe respiratory conditions.

04 Neuromuscular Disorders

Innovative treatments for lower limb spasticity, particularly focusing on post-stroke and traumatic brain injury complications.

  • Spasticity Management
  • Mobility Enhancement
  • Therapeutic Interventions

Clinical evaluation of specialized toxin treatments for improved muscle control and functionality.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.